Green Hygienics Holdings Inc. Secures License for Processing Hemp in the State of North Carolina

SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — via NetworkWire — Green Hygienics Holdings Inc. (OTCQB: GRYN) (“GRYN” or the “Company”), an innovative, full-scope, science-driven premium cannabis cultivation and branding enterprise, is pleased to announce it has secured licenses for the processing of hemp in the state of North Carolina.

The licenses were granted to the Company’s newly formed subsidiary, Coastal Labs North Carolina LLC, by the North Carolina Industrial Hemp Commission.  The North Carolina Department of Agriculture and Consumer Services (Food and Drug Division) provides guidance regarding the manufacture and sale of products that contain CBD.

The Company’s second subsidiary in the state is Green Hygienics North Carolina LLC, which will be partnering for cultivation this year with the intention of meeting the earnings qualification to be licensed on its own for next year’s cultivation.

North Carolina is known to grow about half of all the tobacco in the United States.  Agriculture is North Carolina’s largest industry, and GRYN looks forward to being part of the initiative to create more jobs and economic activity within the sector through its hemp cultivation and processing operations.

About Green Hygienics Holdings Inc. 

Green Hygienics Holdings (OTCQB: GRYN) is a full-scope premium cannabis company with more than 25 years of experience in agricultural science and innovation. Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The Company’s business model includes: generating revenues from the cultivation and sales of premium grade cannabis products; developing and licensing valuable IP; creating trusted global consumer brands; and making strategic acquisitions. Its broader focus is on profitability and creating extraordinary value on behalf of Company shareholders. 
For more information, visit: 

Safe Harbor Statements 
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “estimates,” “intends” or “believes,” or that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “occur,” or “be achieved.” Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. 

Company Contact: Green Hygienics Holdings Inc.
1.855.802.0299 Toll Free

Corporate Communications:NetworkWire (NW)
New York, New York
212.418.1217 Office